Log In
BCIQ
Print this Print this
 

Multiplexed ICE COLD-PCR, MX-ICP (formerly Cold-PCR)

  Manage Alerts
Collapse Summary General Information
Company Transgenomic Inc.
DescriptionHigh-sensitivity mutation detection technology
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect colorectal tumor-associated K-Ras mutations; Detect EGFR mutations in tumor samples; Detect predictors of resistance to 3rd-generation tyrosine kinase inhibitor (TKI) drugs in non-small cell lung cancer (NSCLC) patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/12/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today